Exero Medical

Founded in 2018 in Or Yehuda, Israel, Exero Medical specializes in early detection technologies for gastrointestinal surgery complications.Exero Medical's primary offering is the xBar System, a non-invasive technology designed for early detection of complications following gastrointestinal surgery, particularly anastomotic leaks. The xBar System aims to address the critical need for timely diagnosis and intervention, which can significantly reduce morbidity, mortality, and extended hospital stays associated with delayed leak presentations. The technology utilizes advanced monitoring capabilities to provide healthcare professionals with actionable insights, facilitating earlier interventions and improving patient outcomes. Exero Medical serves a diverse clientele, including hospitals, surgical centers, and healthcare providers focusing on gastrointestinal procedures.Exero Medical operates within a framework that emphasizes partnerships and collaborations with healthcare institutions to support the clinical validation and potential commercialization of the xBar System. Revenue generation primarily revolves around partnerships with hospitals and surgical centers that participate in clinical studies, where they provide access to the xBar System for investigational use.S. market. The company focuses on expanding its presence in international markets by establishing partnerships that validate the technology's effectiveness, anticipating broader market entry following successful trials.

1. Seed

   Feb 13, 2025

   Amount

   $10M

   Investors

   Locked